https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://optometricmanagement.com/media/zjzlmxit/cls_cover.jpg
Contact Lens Spectrum
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://optometricmanagement.com/media/v0idjv0o/_eb1125_higher_res_web_veronica.jpg
Eyecare Business
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://optometricmanagement.com/media/lb0fdylx/november-cover.jpg
Optometric Management
Monday, December 8, 2025
EndoArt, a synthetic endothelial layer for the treatment of chronic corneal edema, is currently designated by the FDA as a Breakthrough Device, according to EyeYon Medical Ltd.
Monday, December 8, 2025
Drug Enforcement Administration recognizes American Optometric Association as physician-level provider of required trainings for prescribers of controlled substances.
Friday, December 5, 2025
VSP Vision has opened applications for the 2026 VSP Vision Innovation Challenge, its third annual global competition aimed at advancing technology and solutions that improve the eyecare experience for both patients and providers.
Thursday, December 4, 2025
The following individuals were elected or re-elected to represent their regions on the board of directors.
Tuesday, December 2, 2025
Cyclosporine ophthalmic emulsion 0.05% is the generic equivalent of Restasis, a registered trademark of Allergan, an AbbVie company.
Tuesday, December 2, 2025
The report features data, infographics, and insights about how consumers of different ages evaluate and interact with providers, practices, and products.
Monday, December 1, 2025
Evoq Technologies receives official FDA registration as a Class I medical device
Monday, December 1, 2025
The phase 3 DRAGON trial demonstrated a statistically significant and clinically meaningful 36% reduction in the growth rate of retinal lesions, measured as definitely decreased autofluorescence by fundus autofluorescence imaging, compared with placebo.
Wednesday, November 26, 2025
From a basement startup to a company supporting clinics in nearly every state with a team of over 130 employees, OBS has been recognized multiple times by the Wichita Business Journal as one of the city’s Best Places to Work.
Tuesday, November 25, 2025
Prevent Blindness has designated Dec. 1-7 as the fifth annual Geographic Atrophy Week, aiming to raise awareness about an advanced form of dry age-related macular degeneration.
Tuesday, November 25, 2025
The agreement includes easier-to-compare contract amendments, among other features.
Tuesday, November 25, 2025
In-house production gives X-Cel and Essilor Contacts complete control over production and quality
Monday, November 24, 2025
New interactive workshops and practice development events await practitioners
Friday, November 21, 2025
The Educators’ Forum Key Takeaways document spotlights global perspectives in optometric education and provides strategic direction for educators, institutions, and policymakers working to strengthen optometry’s role in global health.
Friday, November 21, 2025
Beginning January 2026, practices participating in VSP Premier Edge and PECAA Max (Professional Eye Care Associates of America) will gain access to an enhanced online education platform, expanded recruiting services, and special pricing on select offerings.
Friday, November 21, 2025
The meeting addressed how current tariffs on eyewear components and finished goods are affecting American manufacturers, increasing costs for patients, and challenging the overall competitiveness of the US vision industry.
Friday, November 21, 2025
Leading global experts, policymakers, industry leaders, and advocates convened to publish “Tackling the Myopia Crisis: Uniting Frontline Care, Policy, and Thoughtful Innovation”
Wednesday, November 19, 2025
Both grafts are processed aseptically to preserve the native architecture of the amnion while eliminating the need for cryopreservation.
Wednesday, November 19, 2025
The Omnia system integrates objective refraction, keratometry, tonometry, and pachymetry into a single device.
Monday, November 17, 2025
Latinos en Optometry and VSP Vision blog offers practical guidance for optometrists on reinforcing the connection between diabetes management and ocular health for their Hispanic patients
Monday, November 17, 2025
According to a press release issued by AOA, the Medicare PFS Final Rule announced a slew of changes to take effect on Jan. 1, 2026, to the Medicare conversion factor, telehealth services, facility-setting practice expenses, code valuations, quality payment program measures, and thresholds, among other changes.
Monday, November 17, 2025
The 20/20 Podcast dives into how Gen Z perceives contact lenses, based on new consumer research from Contact Lens Institute.
Monday, November 17, 2025
According to the company, joining the CCOI highlights its commitment to patient-centric innovation across diagnostics, treatment, and data-driven ophthalmology.
Monday, November 17, 2025
The MaximEyes and Mango Voice integration connect telephony, the technology that allows people to communicate by making and placing phone calls, and sharing information across long distances, directly to patient records.
Friday, November 14, 2025
The company hopes to broaden access for patients seeking a flexible option to manage their presbyopia.
Friday, November 14, 2025
According to iOR Partners, the MD/OD OBS model breaks down traditional barriers between referring optometrists and surgeons.
Thursday, November 13, 2025
Designers and brands worldwide are invited to submit their most visionary eyewear creations for the 2026 NOW Awards
Thursday, November 13, 2025
Hyaluronic acid material promises enhanced comfort and performance.
Wednesday, November 12, 2025
Using a compact imaging system, the study observed participants' tear film in real time as they played a virtual reality game for 30 minutes.
Tuesday, November 11, 2025
Investment supports commercialization of decellularized placental tissue technology for ocular surface disease and surgical management
Tuesday, November 11, 2025
“This case demonstrates how targeted ocular surface irrigation can reduce friction and inflammation at the superior limbus—helping to restore comfort and accelerate recovery in patients with challenging ocular surface diseases,” says Cory Lappin, OD, MS, FAAO
Tuesday, November 11, 2025
The program continues to grow year-over-year, driven by the collective efforts of eyecare practices, patients, and consumers, the company says.
Monday, November 10, 2025
The Vision Council (TVC) issued a statement following new executive actions from the White House that alter tariff policies on goods imported from China.
Friday, November 7, 2025
Newton says the combination of its technology and Founders Optical's commitment to service creates an enhanced platform that will benefit eyecare professionals and their patients.
Friday, November 7, 2025
The New England College of Optometry (NECO) convened more than 100 leaders from education, health care, and industry in Boston Nov. 3-4 for its 2025 Industry Collaborative, a 2-day conference examining how technology and cross-sector partnerships are shaping optometric education and patient care.
Wednesday, November 5, 2025
To help spread awareness and provide educational resources on thyroid eye disease (TED), Prevent Blindness has declared November 10-16, 2025, as “TED Week”
Wednesday, November 5, 2025
The study revealed that women are less likely to receive this kind of straightforward vision care, especially in Southeast Asia, East Asia, and Oceania, and in low-income and urban settings.
Wednesday, November 5, 2025
"AOAExcel endorsed VisionHQ because it provides the tools, structure, and support necessary to help make the implementation of these plans easy and sustainable for the long term," says Sam Pierce, OD, American Optometric Association past president and chairman of the board for AOAExcel.
Tuesday, November 4, 2025
As part of the terms of the agreement, Celularity granted DefEYE an exclusive sublicense to Celularity’s ophthalmic biologics portfolio, and Celularity will be the exclusive contract manufacturer for DefEYE’s portfolio of ophthalmic biologics solutions.
Tuesday, November 4, 2025
The global clinical trial in pediatric myopia met the primary efficacy endpoint of proportion of patients with confirmed progression of -0.75 D and a key secondary endpoint of annual progression rate.
Tuesday, November 4, 2025
"He will be a valuable addition to our leadership team and will support our company’s evolution as we advance our clinical development efforts," says Andrew Oxtoby, president and chief executive officer of Kalaris Therapeutics.
Tuesday, November 4, 2025
New online educational resource provides optometrists with a tool to offer patients that breaks down insurance terms, coverage types, and benefits related to eye exams, glasses and contact lenses, and more
Tuesday, November 4, 2025
Ianalumab 300 mg monthly delivered a clinically meaningful benefit in the global NEPTUNUS-1 and NEPTUNUS-2 phase 3 trials, showing both improvement in disease activity and reductions in patient burden
Monday, November 3, 2025
Increased participation across Myopia Profile’s platforms and partners reflects a worldwide movement to prioritize myopia management, according to the online educational platform
Monday, November 3, 2025
Proceeds from Series B financing will support the completion of AAVantgarde’s AAVB-039 CELESTE study, the STELLA natural history study, and the AAVB-081 LUCE phase 1/2 clinical trial.
Saturday, November 1, 2025
A study using multimodal imaging reveals Age-Related Eye Disease Study (AREDS) vitamins have no significant effect on overall geographic atrophy (GA) growth.
Thursday, October 30, 2025
The program recognizes early-career optometrists who demonstrate excellence, entrepreneurship, and a commitment to service.
Thursday, October 30, 2025
Prevent Blindness has announced a suite of new educational tools and resources in recognition of Diabetes-related Eye Disease Month this November, aimed at helping patients understand and manage the vision complications associated with diabetes.
Thursday, October 30, 2025
For the second year in a row ASCO's US institutions received the highest number ever of applicants during the 2024-2025 OptomCAS application cycle.
Thursday, October 30, 2025
Dompé says it plans to apply the voucher to its Biologics License Application for an intranasal form of nerve growth factor (Cenegermin-bkbj) for the treatment of non-arteritic anterior ischemic optic neuropathy (NAION).
Thursday, October 30, 2025
The NDA for SYD-101 was supported by the results of the phase 3 STAR trial, which evaluated more than 800 children aged 3-14 at treatment initiation.
Wednesday, October 29, 2025
According to NextGen Healthcare, the collaboration between the 2 companies will help providers deliver a more unified clinical and retail experience.
Wednesday, October 29, 2025
“I’m honored to step into the role of chief innovation and education officer at BostonSight. I’m deeply committed to expanding access to life-changing scleral lens technology and equipping practitioners with the knowledge and tools they need to transform patient care," says Dr. Carrasquillo.
Tuesday, October 28, 2025
The event featured experts from across technology, health care, and digital culture
Tuesday, October 28, 2025
The phase 2 GALAXY trial is designed to evaluate the efficacy and safety of xelafaslatide (formerly ONL1204) in patients who have geographic atrophy associated with dry age-related macular degeneration
Tuesday, October 28, 2025
Candidates were required to submit a brief essay detailing their most meaningful contact lens patient.
Friday, October 24, 2025
The 13-member ACOE has appointed Julie DeKinder, OD, as chair, Michelle Welch, OD, as vice chair, and has named former Chair, G. Timothy Petito, OD, council member member and key resource
Thursday, October 23, 2025
The 2 nonprofits have renewed their partnership for 2 more years, extending an 8-year collaboration that provides free vision care to children.
Thursday, October 23, 2025
The partnership aims to challenge the misconception that vision changes are simply a normal part of aging, while raising awareness about the signs, risk factors, and treatment of geographic atrophy
Wednesday, October 22, 2025
IDHea will operate with its own governance structure and collaborate closely with a consortium of industry, clinical, and technology partners.
Wednesday, October 22, 2025
New study shows machine learning algorithm significantly outperformed human graders at diagnosing glaucoma.
Monday, October 20, 2025
The company's digital SLT+YAG platform now features advanced HD imaging and seamless connectivity, among other features.
Monday, October 20, 2025
Artificial intelligence can offer insights from clinical data and aid in accurate diagnoses, as well as disease monitoring.
By Sarah Fackler, staff writer
Monday, October 20, 2025
The treatment offers an incision-free alternative to traditional corneal cross-linking procedures.
Friday, October 17, 2025
Uveitis is the most common form of Inflammatory Eye Disease, but the category also includes conjunctivitis, keratitis, thyroid eye disease, and scleritis.
By Sarah Fackler, staff writer
Thursday, October 16, 2025
Relief for digital eye strain is available
By Sarah Fackler, staff writer
Thursday, October 16, 2025
The new event is designed to foster high-level dialogue and collaboration among ECPs on artificial intelligence, data science, and connected technologies for patient care
By Sarah Fackler, staff writer
Thursday, October 16, 2025
Keynote speaker Michael Bonner encouraged ECPs and compared their responsibility to that of educators.
By Sarah Fackler, staff writer
Wednesday, October 15, 2025
NaturalVue’s proprietary Neurofocus Optics technology, which features an extended depth-of-focus channel, may help slow myopia progression and assist children who have atypical accommodative responses in achieving more normalized accommodation, says Dr. Ashley Tuan.
By Sarah Fackler, staff writer
Tuesday, October 14, 2025
Heidelberg and NetraMind Innovations collaborate on NMI-ChoroidAI
By Sarah Fackler, staff writer
Tuesday, October 14, 2025
The report shows measurable improvements in children’s lives.
By Sarah Fackler, staff writer
Tuesday, October 14, 2025
Contributors focus on benefits and challenges with treatment, predictive models, preventive measures, early detection, and continuous monitoring.
By Sarah Fackler, staff writer
Friday, October 10, 2025
Dr. Cindy Tromans stresses comprehensive, accessible, and equitable eye care as she begins her term.
Thursday, October 9, 2025
The partnership expands federal access to DefEYE’s portfolio of ophthalmic-biologic products, improving eye care for veterans and military patients.
Wednesday, October 8, 2025
Initiatives for those impacted by the Texas floods and LA wildfires at home, and more abroad.
Tuesday, October 7, 2025
The studies detail efficacy and patient satisfaction findings.
Tuesday, October 7, 2025
His priorities include innovation, strengthening relationships, and enhancing performance for high-quality service.
Tuesday, October 7, 2025
Therapeutics and diagnostic imaging systems work in tandem to identify and manage ocular surface conditions.
Tuesday, October 7, 2025
The organization is celebrating its 30th anniversary and World Sight Day.
Tuesday, October 7, 2025
The new platform enables instant and accurate eye exam data exchange.
Tuesday, October 7, 2025
Networking will remain central to the event.
Monday, October 6, 2025
The event provided for a unified, pro-patient message to policymakers
By Sarah Fackler, staff writer
Monday, October 6, 2025
“We need to ensure that the potential of optometry is understood to provide sustainable, affordable, and equitable eye care," Dr. Tromans said
By Sarah Fackler, staff writer
Monday, October 6, 2025
People with vision loss, their families, caregivers, and researchers will share a wide range of experiences during Blindness Awareness Month
By Sarah Fackler, staff writer
Monday, October 6, 2025
The organization served 17,747 children from low-income communities during the 2024 to 2025 school year
By Sarah Fackler, staff writer
Friday, October 3, 2025
The NEI-supported research may help to advance understanding of electrical synapse function in vision and neurological health
By Sarah Fackler, staff writer
Friday, October 3, 2025
The initiative emphasizes the importance of comprehensive, in-person eye exams with a doctor of optometry.
By Sarah Fackler, staff writer
Friday, October 3, 2025
The updated formulation is available through optometric and ophthalmic offices, retail pharmacies, and online retailers.
By Sarah Fackler, staff writer
Friday, October 3, 2025
The 2-day program featured top clinical content and hands-on wet lab training
By Sarah Fackler, staff writer
Wednesday, October 1, 2025
The company's portfolio of decellularized human placenta-derived biologics will be available at the upcoming American Academy of Optometry meeting
By Sarah Fackler, staff writer
Tuesday, September 30, 2025
Professional product sample distribution has been initiated nationwide, and commercial product shipments will be initiated to consumers in October through the company's ePharmacy partner.
Sunday, September 28, 2025
Prevent Blindness offers a variety of free resources to help educate the public on ways to use contact lenses safely and effectively.
Friday, September 26, 2025
Beginning in late 2025 and expanding into 2027, HAFA will provide a single, unified access point for prescribers and patients, offering affordability, streamlined prescribing, and predictable access, Harrow said.
Friday, September 26, 2025
The acquisition centers on MELT-300, a sublingual sedation candidate.
Friday, September 26, 2025
By Jennifer Kirby, managing editor
Wednesday, September 24, 2025
The cloud-based platform facilitates the capture, management, and sharing of diagnostic images
By Sarah Fackler, staff writer
Wednesday, September 24, 2025
The trial from Luxa Biotechnology shows maintained letter gains.
By Sarah Fackler, staff writer
Wednesday, September 24, 2025
The company spotlights its net plastic neutrality initiative
By Sarah Fackler, staff writer
Tuesday, September 23, 2025
Look for performance data on Ask Kate at AAO on October 9
By Sarah Fackler, staff writer
Tuesday, September 23, 2025
CEO of ophthalmic equipment company will be honored at a gala on March 11, 2026 at Vision Expo.
By Sarah Fackler, staff writer
Tuesday, September 23, 2025
Details on the location and agenda
By Sarah Fackler, staff writer
Friday, September 19, 2025
The formulation aims to avoid dilation and anticholinergic side effects
By Sarah Fackler, staff writer
Friday, September 19, 2025
A total of 91% of wearers experienced a reduction in issues linked to digital eye strain
By Sarah Fackler, staff writer
Friday, September 19, 2025
Financing options include loans for practice expansion and renovation, acquisitions, and equipment, and special interest rate reductions
By Sarah Fackler, staff writer
Wednesday, September 17, 2025
Findings from the Contact Lens Institute's latest report will be featured at Vision Expo West.
Tuesday, September 16, 2025
The companies aim to support both pre- and postoperative care
By Sarah Fackler, staff writer
Tuesday, September 16, 2025
The speech will highlight themes of resilience, empathy, action, and more
By Sarah Fackler, staff writer
Tuesday, September 16, 2025
Add-on solutions available for demonstration at Vision Expo West 2025.
By Sarah Fackler, staff writer
Tuesday, September 16, 2025
The new policy updates terms, provides resources to ECPs, and more
By Sarah Fackler, staff writer
Tuesday, September 16, 2025
The Vision Council will present findings from their report at Vision Expo West 2025.
By Sarah Fackler, staff writer
Tuesday, September 16, 2025
Company makes available clinical and refractive solutions
By Sarah Fackler, staff writer
Monday, September 15, 2025
Student Leadership Society members are second- or third-year optometry students selected by their faculty to serve a 1-year term.
Thursday, September 11, 2025
Thursday, September 11, 2025
Researchers note further prospective and mechanistic studies are needed.
By Jennifer Kirby, managing editor
Thursday, September 11, 2025
Neurolens has rebranded as Newton, invoking Sir Isaac Newton’s legacy and positioning the company as an innovation-driven leader in eye care technologies.
Thursday, September 11, 2025
An essay on sustainability will be required for candidacy.
Thursday, September 11, 2025
The VSP Vision Exam Rebate, which has delivered $58 million to more than 2,800 practices since 2023, will continue through 2026 to help sustain private practice revenue amid economic challenges.
Wednesday, September 10, 2025
Treatment challenges were reported by optometrists.
Wednesday, September 10, 2025
Bausch + Lomb Corporation announced the US launch of Asana gas permeable (GP) lenses, which are available in spherical, aspheric, toric, multifocal, multifocal toric, reverse geometry and keratoconic prescriptions.
Wednesday, September 10, 2025
Center features larger testing capacity.
Friday, September 5, 2025
Thursday, September 4, 2025
A new platform is an update from the earlier HPE-910 model for in-office lens finishing systems.
Thursday, September 4, 2025
The lenses achieved clinical and statistical significance in a 2020 trial.
Wednesday, September 3, 2025
Patients and their families can experience how different IOL types will function in their daily lives
By Sarah Fackler, staff writer
Wednesday, September 3, 2025
The program focuses on helping more patients discover eye care
By Sarah Fackler, staff writer
Wednesday, September 3, 2025
Myopia Profile provides free resources, education, and more for ECPs who want to advance myopia management in their practices.
By Sarah Fackler, staff writer
Wednesday, September 3, 2025
Prevent Blindness found a 33% increase in sports-related eye injuries since 2023 and offers guidance on proper eye protection
By Sarah Fackler, staff writer
Tuesday, September 2, 2025
As part of a newly announced clinical project in Lusaka, Zambia, Heidelberg Engineering will deploy its Anterion advanced multi-disciplinary imaging platform.
Thursday, August 28, 2025
Retrospective cohort study of Medicare Part B claims finds substantial increase in utilization and costs of sutureless ocular amniotic membrane grafts.
By Sarah Fackler, staff writer
Thursday, August 28, 2025
The companies are targeting new melanocortin mechanisms for diabetic retinopathy.
By Sarah Fackler, staff writer
Thursday, August 28, 2025
Combined with orphan status, this designation creates a regulatory pathway that is intended to expedite ADX-2191’s development.
By Sarah Fackler, staff writer
Thursday, August 28, 2025
Higher serum 25(OH)D quartiles were inversely associated with cataract risk.
By Sarah Fackler, staff writer
Wednesday, August 20, 2025
Exhibit hall, main stage, education, and networking features
By Sarah Fackler, staff writer
Wednesday, August 20, 2025
Lab services and specialty vision products are available to PECAA Max members
By Sarah Fackler, staff writer
Wednesday, August 20, 2025
Fast-rising optometrists receive hands-on instruction, leadership development sessions, and more in 3-day program
By Sarah Fackler, staff writer
Tuesday, August 19, 2025
Optometry practices, student groups, and related businesses will organize raffles, bake sales, office contests, and more fundraising activities
By Sarah Fackler, staff writer
Thursday, August 14, 2025
Diabetes-related retinopathy affects more than 1 in 4 Americans.
By Sarah Fackler, staff writer
Thursday, August 14, 2025
The 2024 to 2025 cycle saw the highest number of applicants in history, including Black and Hispanic/Latino applicants.
By Sarah Fackler, staff writer
Thursday, August 14, 2025
Poor sleep, low physical activity (PA), and high sedentary behavior (SB) were found to be both independently and jointly linked with an increased risk of cataract, according to a recent cross-sectional analysis, published in BMC Medicine.
By Jennifer Kirby, managing editor
Thursday, August 14, 2025
A Special Protocol Assessment (SPA) establishes a regulatory path for Ocular Therapeutix’s Axpaxli in diabetic eye disease.
Tuesday, August 12, 2025
Additional workshops are coming in the fall.
By Sarah Fackler, staff writer
Monday, August 11, 2025
“Too often, inflammation and eyelid margin disease are treated as afterthoughts....Our goal is to give ODs a clinical playbook they can use Monday morning," says host Marc Bloomenstein, OD.
Monday, August 11, 2025
The collaboration aims to promote healthy workplace vision across essential industries, with a focus on underserved communities and specialized medical needs.
By Sarah Fackler, staff writer
Thursday, August 7, 2025
New building aims to increase patient access
By Jennifer Kirby, managing editor
Thursday, August 7, 2025
More than 70 optometrists are actively leading efforts to reshape the landscape of childhood myopia care in the United States.
By Sarah Fackler, staff writer
Wednesday, August 6, 2025
The update reflects the company’s values and vision for the future.
By Sarah Fackler, staff writer
Wednesday, August 6, 2025
The acquisition supports high quality standards in existing and new categories—such as wearables.
By Sarah Fackler, staff writer
Wednesday, August 6, 2025
Expansion of Chemistrie clip-on lens line to follow
By Sarah Fackler, staff writer
Thursday, July 31, 2025
Near vision improvements were demonstrated within 30 minutes and lasted up to 10 hours in clinical trials.
Thursday, July 31, 2025
“These students exemplify what it means to lead with both clinical skill and compassion.”
By Sarah Fackler, staff writer
Wednesday, July 30, 2025
A growing body of sports vision research connects enhanced perceptual skills to improved performance on the field
By Sarah Fackler, staff writer
Wednesday, July 30, 2025
This year marks the fifth consecutive year CooperVision has used national media to drive pediatric myopia awareness.
By Sarah Fackler, staff writer
Wednesday, July 30, 2025
Prevent Blindness provides new resources
By Sarah Fackler, staff writer
Wednesday, July 30, 2025
Mini-dec is both easier to manufacture and is formulated for topical delivery via eye drops
By Sarah Fackler, staff writer
Tuesday, July 29, 2025
More than 400 patients have been enrolled and randomized in the pivotal phase 3 trial of Duravyu for treatment of wet age-related macular degeneration.
Friday, July 25, 2025
“My hope is that understanding how these neurons behave when visual signals start to disappear from the retina will let us design better vision testing for early diagnosis,” lead researcher says.
By Sarah Fackler, staff writer
Friday, July 25, 2025
Plus, an updated list of authorized AI-enabled products from the FDA
By Sarah Fackler, staff writer
Friday, July 25, 2025
She will lead efforts to expand the college’s impact in both academic and clinical settings, while upholding its long-standing reputation in optometric education.
By Sarah Fackler, staff writer
Wednesday, July 23, 2025
A coalition of leading eye care and research organizations has launched a nationwide campaign to protect the National Eye Institute (NEI) from proposed federal restructuring and funding cuts.
Wednesday, July 23, 2025
The collaboration aims to accelerate development of OPGx-RDH12, a gene therapy for RDH12-associated Leber congenital amaurosis.
Monday, July 21, 2025
ISO 13485:2016 certification covers relabeling and repackaging of contact lenses and kit assembly
By Sarah Fackler, staff writer
Wednesday, July 16, 2025
Speakers will discuss empowerment to drive equity in optometry.
By Sarah Fackler, staff writer
Wednesday, July 16, 2025
After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in neuropathic corneal pain.
By Sarah Fackler, staff writer
Wednesday, July 16, 2025
Their successes, areas for continued monitoring, exclusions, and next steps
By Sarah Fackler, staff writer
Tuesday, July 15, 2025
The therapy does not require surgical intervention, repeat dosing, or genetic testing, and offers broad applicability to RP patients regardless of genetic subtype.
By Sarah Fackler, staff writer
Friday, July 11, 2025
The benefits tended to wane 2 weeks after discontinuation of exercises.
By Sarah Fackler, staff writer
Wednesday, July 9, 2025
The coating reflects near-infrared light and disrupts facial recognition or ocular mapping technologies as use of IR surveillance systems becomes more widespread.
By Sarah Fackler, staff writer
Wednesday, July 9, 2025
Researchers make the case for upper eyelid assessment in patients who have MGD, from contact lens wearers to cataract surgery candidates and those with autoimmune conditions.
By Sarah Fackler, staff writer
Tuesday, July 8, 2025
Providing a foundation for the upcoming 2025 IMI White Paper series.
By Sarah Fackler, staff writer
Tuesday, July 1, 2025
The research will examine how real-world visual scenes influence eye growth, refine RLRL therapy, and develop objective recommendations for artificial lighting.
By Sarah Fackler, staff writer
Tuesday, July 1, 2025
Experienced practitioners exchanged best practices for fitting advanced and custom contact lenses, plus broader topics such as practice growth, patient engagement, and operational efficiency.
By Sarah Fackler, staff writer
Tuesday, July 1, 2025
Practical strategies for growing contact lens practices.
By Sarah Fackler, staff writer
Tuesday, July 1, 2025
The new branding prioritizes visual accessibility.
By Sarah Fackler, staff writer
Tuesday, July 1, 2025
88% of survey respondents who are currently using prescription treatments said they wish they had started sooner.
By Sarah Fackler, staff writer
Friday, June 27, 2025
The British Contact Lens Association Industry Award honors organizations that have made significant contributions to anterior eye care through innovation, research, and education.
By Sarah Fackler, staff writer
Friday, June 27, 2025
The initiative aims to improve understanding of the condition, highlight risk factors, and encourage early diagnosis and treatment to prevent long-term damage and improve quality of life.
By Sarah Fackler, staff writer
Wednesday, June 25, 2025
The challenge includes a $1,500 travel grant and the opportunity to present their research at GSLS in January 2026.
By Sarah Fackler, staff writer
Wednesday, June 25, 2025
Nearly 40% of US adults do not wear sunglasses regularly, despite the risks of prolonged UV exposure.
Wednesday, June 25, 2025
The report provides how-to articles, infographics, and more to help eyecare professionals adapt communication, education, and practice management strategies based on evolving digital behaviors.
By Sarah Fackler, staff writer
Wednesday, June 25, 2025
The lenses performed well in clinical trials and address the previous gap in available options for patients with both conditions.
By Sarah Fackler, staff writer
Tuesday, June 24, 2025
Vision Expo, organized by The Vision Council and RX, announced it will consolidate into a single annual event beginning in March 2026. The new format replaces the current biannual schedule and will rotate among major U.S. cities.
Tuesday, June 24, 2025
The agreement provides up to $2 million in nondilutive financing aimed at accelerating treatment development for retinitis pigmentosa.
By Sarah Fackler, staff writer
Tuesday, June 24, 2025
The initiative offers 2 clinically validated myopia interventions for the duration of treatment at no cost.
By Sarah Fackler, staff writer
Friday, June 20, 2025
The testimony urged US Senate subcommittee to deliver strong, sustained funding for the NEI and maintain the NEI’s status as an independent NIH institute in the FY2026 appropriations cycle.
By Sarah Fackler, staff writer
Friday, June 20, 2025
The organization is celebrating empowerment, connection, and promotion of women ODs over the past decade.
By Sarah Fackler, staff writer
Friday, June 20, 2025
OD-related news for the week of June 16.
Wednesday, June 18, 2025
Fundus refraction offset provides several avenues for research in myopia trajectory risks.
By Sarah Fackler, staff writer
Friday, June 13, 2025
OD-related news for the week of June 9.
Friday, June 13, 2025
Comorbidities, such as dementia, cardiovascular issues, and diabetes, also pointed to higher mortality in ocular trauma cases.
By Sarah Fackler, staff writer
Monday, June 9, 2025
Study inclusion criteria were patients age 66 or older who had diabetes and a minimum follow-up period of 12 months following this initial diagnosis.
Friday, June 6, 2025
An evaluation of NIBUT and MG may aid in diagnosing thyroid disorders.
Thursday, June 5, 2025
OD-related news for the week of June 2.
Thursday, June 5, 2025
Researchers outline risks associated with contact lens wear, age, and more.
By Sarah Fackler, staff writer
Tuesday, June 3, 2025
The FDA has set a Prescription Drug User Fee Act (PDUFA) date of January 28, 2026, for the drug.
Friday, May 30, 2025
OD-related news for the week of May 26.
Thursday, May 29, 2025
The drug is a TRPM8 receptor agonist designed to stimulate corneal sensory nerves and increase basal tear production.
By Sarah Fackler, staff writer
Thursday, May 29, 2025
The scattering also predicted formal diagnosis, even when they didn’t align with PET amyloid scans.
By Sarah Fackler, staff writer
Wednesday, May 28, 2025
“Patients with better vision fear cataract surgery more,” researchers found.
By Sarah Fackler, staff writer
Friday, May 23, 2025
Prevalence of refractive astigmatism increased more than 10% between 2019 and 2023, while prevalence of corneal astigmatism increased 6%.
By Sarah Fackler, staff writer
Friday, May 23, 2025
OD-related news for the week of May 19.
Friday, May 16, 2025
OD-related news for the week of May 12.
Tuesday, May 13, 2025
Friday, May 9, 2025
News for the week of May 5.
Friday, May 2, 2025
OD-related news for the week of April 28
Wednesday, April 30, 2025
A look at the link between optometry and The Great Gatsby.
By Jennifer Kirby, managing editor
Friday, April 25, 2025
OD-related news for the week of April 21.
Friday, April 18, 2025
OD-related news for the week of April 13.
Friday, April 11, 2025
OD-related news for the week of April 7.
Friday, April 4, 2025
OD-related news for the week of March 31.
Friday, March 28, 2025
OD-related news for the week of March 24.
Wednesday, March 26, 2025
Nipocalimab is an investigational monoclonal antibody from Johnson & Johnson.
Friday, March 21, 2025
OD-related news for the week of March 17.
Friday, March 7, 2025
OD-related news for the week of March 3.
Wednesday, March 5, 2025
Genes play larger role in determining risk of glaucoma as patients age
Thursday, February 27, 2025
OD-related news for the week of February 24.
Friday, February 21, 2025
OD-related news for the week of February 17
Friday, February 14, 2025
Happy Valentine's Day, and OD-related news for the week of Feb. 10.
Wednesday, February 12, 2025
AI assists in diagnosis
Friday, February 7, 2025
OD-related news for the week of Feb. 3.
Friday, January 31, 2025
OD-related news for the week of Jan. 27
Tuesday, January 28, 2025
Friday, January 24, 2025
OD-related news for the week of Jan. 20
Friday, January 17, 2025
OD-related news for the week of Jan. 13.
Friday, January 17, 2025
Short-term exposure to traffic-related air pollutants were linked with a risk of dry eye disease outpatient visits.
Thursday, January 16, 2025
Attention private practice owners: The U.S. Small Business Administration (SBA) has opened two Business Recovery Centers (BRC) in Los Angeles County to help.
Monday, January 13, 2025
President Biden signed into law the Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act
Friday, January 10, 2025
OD-related news for the week of Jan. 6.
Friday, January 3, 2025
OD-related news from Dec. 23, 2024 to Jan. 3, 2025
